ANI Pharmaceuticals (NASDAQ:ANIP) just reported results for the first quarter of 2024.
- ANI Pharmaceuticals reported earnings per share of $1.21. This was above the analyst estimate for EPS of 99 cents.
- The company reported revenue of $137.43 million.
- This was 9.49% better than the analyst estimate for revenue of $125.52 million.